Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in EOLS — Evolus, Inc.

CIK 1109448 NASHVILLE, TN
Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$481,913
+$225,696 QoQ
Shares Held
69,440
+11.4% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 158 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $485,105,474 across 44 Drug Manufacturers - Specialty & Generic names. EOLS ranks #32 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 234,607 $127,117,110
2 NBIX
Neurocrine Biosciences Inc
 461,270 $77,742,445
3 RDY
Dr Reddys Laboratories Ltd
 3,730,713 $54,058,031
4 ZTS
Zoetis Inc.
 698,452 $50,190,760
5 KNSA
Kiniksa Pharmaceuticals International, plc
 556,151 $35,565,856
6 VTRS
Viatris Inc
 1,233,234 $19,583,755
7 ELAN
Elanco Animal Health Inc
 621,675 $15,299,421
8 HIMS
Hims & Hers Health, Inc.
 438,863 $15,215,380

All Filings in EOLS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $481,913 69,440
2026-03-31 $256,217 62,340
2025-12-31 $414,561 62,340
2025-09-30 $382,767 62,340
2025-06-30 $575,072 62,440
2025-03-31 $751,153 62,440
2024-12-31 $689,337 62,440
2024-09-30 $1,011,528 62,440
2024-06-30 $677,474 62,440
2024-03-31 $874,160 62,440
2023-12-31 $615,794 58,480
2023-09-30 $594,648 65,060
2023-06-30 $472,259 64,960
2023-03-31 $438,228 51,800
2022-12-31 $389,018 51,800
2022-09-30 $386,400 48,000
2022-06-30 $972,138 83,805
2022-03-31 $481,338 42,900
2021-12-31 $277,977 42,700
2021-09-30 $325,374 42,700
2021-06-30 $540,155 42,700
2021-03-31 $485,826 37,400
2020-12-31 $218,400 65,000
2020-09-30 $254,150 65,000
2020-06-30 $350,330 66,100
2020-03-31 $232,815 56,100